Neoadjuvant chemotherapy (NAC) is one of the standard-of-care therapies for breast cancer (BC) with axillary lymph node (ALN) metastases. However, the response to this therapy varies depending on the ...
SAN ANTONIO — Women with early breast cancer who have less extensive axillary surgery see no effect on their 10-year rates of locoregional recurrence and mortality than do those who have more ...
The management of axillary lymph nodes in breast cancer is continually evolving. Recent data now support omitting axillary lymph node dissection (ALND) in most patients with metastases in up to two ...
The study in brief: interdisciplinary research // peer-reviewed publication // cohort study // number of patients in the study: 1,265 // statistical correlation // retrospective A project at Lund ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results